Analyst
Barclays
Equibles does not estimate personal net worth.
Glenn Centangelo is recorded as Analyst at Barclays. Glenn Centangelo has spoken on 2 earnings calls across 2 companies, most recently for Claritev Corp on November 9, 2026. Those appearances were for Claritev Corp (CTEV) and Hims & Hers Health, Inc. (HIMS). The companies whose calls Glenn Centangelo spoke on are classified in the Healthcare sector.
“You know, Travis, I also wanted to follow up, you know, on the outperformance in the claims intelligence business. In sort of your prepared remark, you know, you obviously talked about the NSA and the key driver it's been, and you're making the case that it's going to persist.”
“Oh, yeah, thanks for taking my question. Hey, I just want to follow up on the 4Q U.S. revenue number being up 17%. I was kind of curious, if we were to sort of parse out the compounded GLP-1 revenue, would the compounded GLP-1 a headwind or a tailwind to that number?”
Barclays
Analyst
Transcript header (unverified)
CTEV
Health Information Services · Healthcare
Drug Manufacturers - Specialty & Generic · Healthcare
